Cargando…

Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy

OBJECTIVE: To determine the efficacy of topical Nepafenac (0.1%), administered post-operatively in prevention of Macular Edema (ME), after cataract surgery in patients with Non-Proliferative Diabetic Retinopathy (NPDR). METHODS: This randomized control trial was conducted at Armed Forces Institute o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarfraz, Muhammad Haroon, Haq, Rana Intisar Ul, Mehboob, Mohammad Asim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368311/ https://www.ncbi.nlm.nih.gov/pubmed/28367202 http://dx.doi.org/10.12669/pjms.331.11644

Ejemplares similares

Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
por: Singh, Rishi, et al.
Publicado: (2012)

Topical nepafenac in the treatment of diabetic macular edema
por: Callanan, David, et al.
Publicado: (2008)

Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
por: Yüksel, Bora, et al.
Publicado: (2017)

Correlation between central corneal thickness and visual field defects, cup to disc ratio and retinal nerve fiber layer thickness in primary open angle glaucoma patients
por: Sarfraz, Muhammad Haroon, et al.
Publicado: (2017)

Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac
por: Sengupta, Sabyasachi, et al.
Publicado: (2018)

Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
por: Giarmoukakis, Athanassios K, et al.
Publicado: (2020)

Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac
por: Cervantes-Coste, Guadalupe, et al.
Publicado: (2009)

Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
por: Aaronson, Alexander, et al.
Publicado: (2020)

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
por: Hariprasad, Seenu M, et al.
Publicado: (2009)

Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo
por: McCafferty, Sean, et al.
Publicado: (2017)

Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery
por: Tripathi, Amruta S
Publicado: (2022)

Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications
por: Husmann, Rachel, et al.
Publicado: (2020)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
por: Marques, Ines P., et al.
Publicado: (2020)

Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
por: Graham, Patricia S., et al.
Publicado: (2018)

Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
por: Sheppard, John D
Publicado: (2016)

Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy
por: Khodabandeh, Alireza, et al.
Publicado: (2018)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
por: Choi, Wungrak, et al.
Publicado: (2020)

Topical Nepafenac in Treatment of Acute Central Serous Chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2013)

Comparison of the efficacy of Diclofenac 0.1% and Nepafenac 0.1% on anterior chamber cells in patients undergoing cataract surgery: A prospective clinical practice trial
por: Ahmad, Adnan, et al.
Publicado: (2023)

Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery
por: Nardi, M, et al.
Publicado: (2007)

Macular Edema and Visual Acuity Observation after Cataract Surgery in Patients with Diabetic Retinopathy
por: Song, Ruiying, et al.
Publicado: (2022)

Laser Photocoagulation Combined with Intravitreal Triamcinolone Acetonide Injection in Proliferative Diabetic Retinopathy with Macular Edema
por: Choi, Kyung Seek, et al.
Publicado: (2007)

Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
por: Someya, Hideaki, et al.
Publicado: (2019)

Effect of panretinal photocoagulation on macular morphology and thickness in eyes with proliferative diabetic retinopathy without clinically significant macular edema
por: Soman, Manoj, et al.
Publicado: (2012)

Macular Edema Formation and Deterioration of Retinal Function after Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy
por: Imai, Hisanori, et al.
Publicado: (2011)

Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study
por: Aljundi, Wissam, et al.
Publicado: (2022)

Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?
por: Arabi, Amir, et al.
Publicado: (2022)

Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
por: Xie, Xiao, et al.
Publicado: (2023)

Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients
por: Andrés-Blasco, Irene, et al.
Publicado: (2023)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
por: Gaynes, Bruce I, et al.
Publicado: (2008)

Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema
por: Markan, Ashish, et al.
Publicado: (2020)

Effects of Topical Nepafenac and Fluorometholone on Macular Thickness After Posterior Capsulotomy Using Neodymium-doped Yttrium-Aluminum-Garnet Laser
por: Atilgan, Cemile Ucgul, et al.
Publicado: (2020)

Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy
por: Guan, Jian, et al.
Publicado: (2020)

Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2
por: Batsos, Georgios, et al.
Publicado: (2022)

Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
por: Do, Diana V., et al.
Publicado: (2022)

Primary Effects of Intravitreal Bevacizumab in Patients with Diabetic Macular Edema
por: Tareen, Iftikhar-ul-Haq, et al.
Publicado: (2013)

Effect of preoperative topical diclofenac on intraocular interleukin-12 concentration and macular edema after cataract surgery in patients with diabetic retinopathy: a randomized controlled trial
por: Medić, Aleksej, et al.
Publicado: (2017)

Cystoid Macular Edema in Bietti's Crystalline Retinopathy
por: Saatci, Ali Osman, et al.
Publicado: (2014)

Association of Subregional Quantitative Ultra-widefield Fluorescence Angiography Characteristics With the Occurrence of Diabetic Macular Edema and Proliferative Diabetic Retinopathy
por: Sun, Gongpeng, et al.
Publicado: (2021)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
por: Udaondo, Patricia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_or2frjfk1818e5cij5paek2eme